Business
Groupe Athena, Inc. Releases Year End Financials, Posts Strong Growth
Groupe Athena, Inc. Releases Year End Financials, Posts Strong Growth.

About this update from Ayujoy Herbals Ltd.
[{"type":"text","content":"\nMumbai, India, July 17, 2018 (GLOBE NEWSWIRE) -- Groupe Athena, Inc. (Pink sheets GATA.PK) is very excited to post the results for their fiscal year ending June 30, 2018. Annual revenue for the period was $55,968,325. EBITDA for the year was also strong at $8,067,798 and net after tax income for the period was $6,394,061 or $.14 per share, a growth of 95% over the previous year.\n Company Chairman, D. Purohit stated, “This is a very exciting time for Groupe Athena, Inc., and as dynamics within our industry evolve, we are seeing many exciting opportunities unfold that we hope to capitalize on in the near to medium term.”  The company expects to use a substantial portion of their retained earnings to further continue their research & development initiatives.  To review the complete quarterly report please go to:  https://www.otcmarkets.com/stock/GATA/disclosure. The Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation.  About Groupe Athena, Inc.  Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.   The company has a research and marketing facility in India that currently employs 21 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company’s web address is www.groupeathena.com Safe Harbor Statement Certain statements set forth in this press release constitute \"forward-looking statements.” Forward-looking statements include, without limitation, any stateme...